Oriana Jimena López Godino

Torrent A, Morgades M, Garcia-Calduch O, de Llano MPQ, Montesinos P, Navarro I, Hernandez-Rivas JM, Barez-Garcia A, Gonzalez-Campos J, Oiartzabal I, Valero M, Cervera M, Zudaire T, Albors-Ferreiro M, Lopez-Godino O, Gil-Cortes C, Villalon L, Saldana R, Ribera JM. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. Eur J Haematol. 2023 Sep;111(3):485-490. doi: 10.1111/ejh.14031. Epub 2023 Jun 28. PubMed PMID: 37381686.

AÑO: 2023; IF: 3.1

37381686

Bailen R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Valles A, Esquirol A, Fonseca M, Solan L, Sanchez-Vadillo I, Bautista G, Bento L, Lopez-Godino O, Perez-Martinez A, Torrent A, Zanabili J, Calbacho M, Moreno MA, Pascual-Cascon MJ, Guerra-Dominguez L, Chinea A, Garcia-Cadenas I, Lopez-Corral L, Boix-Giner F, Lopez Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernandez-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PubMed PMID: 37304258; PubMed Central PMCID: PMC10250708.

AÑO: 2023; IF: 7.3

37304258

Medina I, Carpio C, Ruiz-Camps I, Albasanz-Puig A, Lopez-Godino O, Esperalba J, Beas F, Sanchez-Salinas M, Iacoboni G, Barba P. Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma. Immunotherapy. 2023 Sep 18. doi: 10.2217/imt-2023-0111. Online ahead of print. PubMed PMID: 37718888.

AÑO: 2023; IF: 2.8

37718888

Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquen A, Briones J, Caballero AC, Campos A, Espanol I, Ferra C, Lopez SG, Gonzalez Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jimenez-Ubieto A, Kwon M, Corral LL, Lopez-Godino O, Munoz MCM, Martinez-Cibrian N, Gomez JM, Perez-Ortega L, Orti G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yanez L, Varela R, Echechipia IC, Caballero D, Sureda A. Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. Bone Marrow Transplant. 2023 Jun;58(6):738. doi: 10.1038/s41409-023-01967-9. No abstract available. PubMed PMID: 37076611.

AÑO: 2023; IF: 4.8

37076611

Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquen A, Briones J, Caballero AC, Campos A, Espanol I, Ferra C, Lopez SG, Gonzalez Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jimenez-Ubieto A, Kwon M, Corral LL, Lopez-Godino O, Munoz MCM, Martinez-Cibrian N, Gomez JM, Perez-Ortega L, Orti G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yanez L, Varela R, Echechipia IC, Caballero D, Sureda A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. Bone Marrow Transplant. 2023 Jun;58(6):673-679. doi: 10.1038/s41409-023-01949-x. Epub 2023 Mar 14. Erratum In: Bone Marrow Transplant. 2023 Apr 19;: PubMed PMID: 36918682.

AÑO: 2023; IF: 4.8

36918682